ASTS Down 54%: FCC and BlueBird Milestones Yet to Reverse Sentiment
Read source articleWhat happened
AST SpaceMobile shares have fallen 54% from their 2026 peak as the market shifts from concept validation to execution risk around launch cadence and service monetization. Despite FCC authorization for 248 satellites and 13 BlueBirds in orbit, the company has still not launched its SpaceMobile Service and recorded zero service revenue. Management's latest filings show a target of about 45 satellites by early 2027, a slip from the prior end-2026 goal, while only 6.6% of $1.2B in remaining performance obligations converts within 12 months. Liquidity remains strong at over $3.7B pro forma after July convert, but that has not prevented valuation compression as investors question whether pre-commercial milestones justify the current price. The latest article asks whether FCC progress and BlueBird launches can reverse the slide, but our analysis suggests the key is first recognized service revenue, not just regulatory or orbital wins.
Implication
The stock is now pricing a binary outcome: successful commercialization toward $85 or further delay toward $40, with limited margin for error at current levels. Holders should treat the next 3-6 months as a check-point window: if BlueBirds 14-16 launch and operate successfully, and AST discloses beta service with concrete markets, the thesis strengthens. However, if the company enters 2027 without recognized SpaceMobile Service revenue or slips the early-2027 constellation target again, the equity could re-rate as a longer-dated capital project. The $45M Verizon prepayment and conversion of backlog are early signals to monitor; any sign that carrier partners are delaying integration would weaken the bull case. We maintain a WAIT rating and would look to add only after first service revenue is confirmed or the stock reaches the $52 attractive entry zone with execution intact.
Thesis delta
The thesis has not fundamentally changed, but the market's repricing from optimism to execution risk aligns with our WAIT rating. FCC approval and BlueBird launches validate the architecture, yet the core proof—paid service revenue—remains absent. The next catalyst window will determine whether the stock deserves a re-rating or further derating.
Confidence
High